Replies to post #180500 on Biotech Values

[DewDiligence]

GILD hardly ever makes a misstep; however, if GILD ends up having to pay ABBV even a tiny-percentage royalty on sales of the Sovaldi + Ledipasvir combination because ABBV patented the “method of use” first, it will be a screw-up of colossal proportions.

[jq1234]

CVS officials say Sovaldi pricing in line with history, but unsustainable

[This reflects almost exactly my view of Sovaldi pricing]

Brennan and Shrank point out that Hepatitis C treatments could add $200 to $300 on to annual health insurance premiums for every American for each of the next five years. Sovaldi is what they call a “total cost outlier” because it’s priced like other specialty medications but treats a fairly large group of patients.

http://m1.marketwatch.com/articles/BL-MW243B-2828?mobile=y&mobile=y

[masterlongevity]

How could they possible patent the combination of 2 gild drugs?